Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 11559 | 972 | 24.1 | 54% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
| 118 | 3 | EPSTEIN BARR VIRUS//LYMPHOMA//HODGKINS DISEASE | 69002 |
| 495 | 2 | EPSTEIN BARR VIRUS//NASOPHARYNGEAL CARCINOMA//HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS | 15379 |
| 11559 | 1 | INFECTIOUS MONONUCLEOSIS//EPSTEIN BARR VIRUS//MONONUCLEOSIS | 972 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | INFECTIOUS MONONUCLEOSIS | authKW | 1515666 | 15% | 34% | 141 |
| 2 | EPSTEIN BARR VIRUS | authKW | 334746 | 23% | 5% | 228 |
| 3 | MONONUCLEOSIS | authKW | 182749 | 2% | 36% | 16 |
| 4 | ACUTE EBV INFECTION | authKW | 94240 | 0% | 100% | 3 |
| 5 | AGE SPECIFIC EBV ANTIBODY PREVALENCE | authKW | 62827 | 0% | 100% | 2 |
| 6 | EBV VCA IGM | authKW | 62827 | 0% | 100% | 2 |
| 7 | ENCEPHALOMYELORADICULITIS | authKW | 62827 | 0% | 100% | 2 |
| 8 | ENCEPHALOMYELORADICULOPATHY | authKW | 62827 | 0% | 100% | 2 |
| 9 | EPIDEMIOLOGY OF EBV INFECTIONS | authKW | 62827 | 0% | 100% | 2 |
| 10 | EPSTEIN BARR VIRUS INFECTION | authKW | 59103 | 2% | 12% | 16 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Infectious Diseases | 3017 | 17% | 0% | 166 |
| 2 | Pediatrics | 1907 | 16% | 0% | 155 |
| 3 | Medicine, General & Internal | 1332 | 18% | 0% | 177 |
| 4 | Virology | 1105 | 9% | 0% | 83 |
| 5 | Microbiology | 997 | 15% | 0% | 141 |
| 6 | Immunology | 739 | 15% | 0% | 143 |
| 7 | Pathology | 345 | 6% | 0% | 58 |
| 8 | Medical Laboratory Technology | 286 | 3% | 0% | 30 |
| 9 | Primary Health Care | 268 | 2% | 0% | 17 |
| 10 | Otorhinolaryngology | 224 | 4% | 0% | 35 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | AREA VIROLIBR | 31413 | 0% | 100% | 1 |
| 2 | BIYOKIM AD | 31413 | 0% | 100% | 1 |
| 3 | BIYOKIMYA AD GATA | 31413 | 0% | 100% | 1 |
| 4 | CNRSRH | 31413 | 0% | 100% | 1 |
| 5 | EBV REFERENCE | 31413 | 0% | 100% | 1 |
| 6 | ENF HAST KL MIK AD | 31413 | 0% | 100% | 1 |
| 7 | FAIRVIEW CLIN VIROL | 31413 | 0% | 100% | 1 |
| 8 | GEN PAEDIAT EMERGENCY MED | 31413 | 0% | 100% | 1 |
| 9 | HALK SAGLIGI AD GATA | 31413 | 0% | 100% | 1 |
| 10 | HISTOPATHOL GREAT ORMOND ST | 31413 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | JOURNAL OF MEDICAL VIROLOGY | 2753 | 3% | 0% | 26 |
| 2 | SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES | 2142 | 2% | 0% | 19 |
| 3 | REVUE DU PRATICIEN | 2001 | 1% | 1% | 7 |
| 4 | PEDIATRIC INFECTIOUS DISEASE JOURNAL | 1911 | 2% | 0% | 24 |
| 5 | CLINICAL AND VACCINE IMMUNOLOGY | 1699 | 1% | 0% | 12 |
| 6 | JOURNAL OF INFECTION | 1362 | 1% | 0% | 13 |
| 7 | CLINICAL AND DIAGNOSTIC VIROLOGY | 1340 | 0% | 1% | 3 |
| 8 | JOURNAL OF CLINICAL MICROBIOLOGY | 1245 | 3% | 0% | 33 |
| 9 | JOURNAL OF CLINICAL VIROLOGY | 1117 | 1% | 0% | 11 |
| 10 | JOURNAL OF INFECTIOUS DISEASES | 1075 | 3% | 0% | 25 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | RAFAILIDIS, PI , MAVROS, MN , KAPASKELIS, A , FALAGAS, ME , (2010) ANTIVIRAL TREATMENT FOR SEVERE EBV INFECTIONS IN APPARENTLY IMMUNOCOMPETENT PATIENTS.JOURNAL OF CLINICAL VIROLOGY. VOL. 49. ISSUE 3. P. 151 -157 | 36 | 77% | 17 |
| 2 | WOMACK, J , JIMENEZ, M , (2015) COMMON QUESTIONS ABOUT INFECTIOUS MONONUCLEOSIS.AMERICAN FAMILY PHYSICIAN. VOL. 91. ISSUE 6. P. 372 -376 | 21 | 95% | 4 |
| 3 | TOPP, SK , ROSENFELDT, V , VESTERGAARD, H , CHRISTIANSEN, CB , VON LINSTOW, ML , (2015) CLINICAL CHARACTERISTICS AND LABORATORY FINDINGS IN DANISH CHILDREN HOSPITALIZED WITH PRIMARY EPSTEIN-BARR VIRUS INFECTION.INFECTIOUS DISEASES. VOL. 47. ISSUE 12. P. 908 -914 | 21 | 91% | 0 |
| 4 | LUPO, J , GERMI, R , SEMENOVA, T , BUISSON, M , SEIGNEURIN, JM , MORAND, P , (2012) PERFORMANCE OF TWO COMMERCIALLY AVAILABLE AUTOMATED IMMUNOASSAYS FOR THE DETERMINATION OF EPSTEIN-BARR VIRUS SEROLOGICAL STATUS.CLINICAL AND VACCINE IMMUNOLOGY. VOL. 19. ISSUE 6. P. 929-934 | 24 | 77% | 3 |
| 5 | GUERRERO-RAMOS, A , PATEL, M , KADAKIA, K , HAQUE, T , (2014) PERFORMANCE OF THE ARCHITECT EBV ANTIBODY PANEL FOR DETERMINATION OF EPSTEIN-BARR VIRUS INFECTION STAGE IN IMMUNOCOMPETENT ADOLESCENTS AND YOUNG ADULTS WITH CLINICAL SUSPICION OF INFECTIOUS MONONUCLEOSIS.CLINICAL AND VACCINE IMMUNOLOGY. VOL. 21. ISSUE 6. P. 817-823 | 17 | 94% | 2 |
| 6 | GUPTA, E , BHATIA, V , CHOUDHARY, A , RASTOGI, A , GUPTA, NL , (2013) EPSTEIN-BARR VIRUS ASSOCIATED ACUTE HEPATITIS WITH CROSS-REACTING ANTIBODIES TO OTHER HERPES VIRUSES IN IMMUNOCOMPETENT PATIENTS: REPORT OF TWO CASES.JOURNAL OF MEDICAL VIROLOGY. VOL. 85. ISSUE 3. P. 519-523 | 17 | 94% | 2 |
| 7 | DE PAOR, M , O'BRIEN, K , FAHEY, T , SMITH, SM , (2016) ANTIVIRAL AGENTS FOR INFECTIOUS MONONUCLEOSIS (GLANDULAR FEVER).COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 12. P. - | 22 | 63% | 0 |
| 8 | HOCQUELOUX, L , CAUSSE, X , VALERY, A , JANDALI, JC , MAITRE, O , SOIN, C , BURET, J , OUANE, F , NIANG, M , MILLE, C , ET AL (2015) THE HIGH BURDEN OF HOSPITALIZATIONS FOR PRIMARY EBV INFECTION: A 6-YEAR PROSPECTIVE SURVEY IN A FRENCH HOSPITAL.CLINICAL MICROBIOLOGY AND INFECTION. VOL. 21. ISSUE 11. P. - | 15 | 94% | 0 |
| 9 | KREUZER, C , NABECK, KU , LEVY, HR , DAGHOFER, E , (2013) RELIABILITY OF THE SIEMENS ENZYGNOST AND NOVAGNOST EPSTEIN-BARR VIRUS ASSAYS FOR ROUTINE LABORATORY DIAGNOSIS: AGREEMENT WITH CLINICAL DIAGNOSIS AND COMPARISON WITH THE MERIFLUOR EPSTEIN-BARR VIRUS IMMUNOFLUORESCENCE ASSAY.BMC INFECTIOUS DISEASES. VOL. 13. ISSUE . P. - | 14 | 100% | 2 |
| 10 | CORRALES, I , GIMENEZ, E , NAVARRO, D , (2014) EVALUATION OF THE ARCHITECT EPSTEIN-BARR VIRUS (EBV) VIRAL CAPSID ANTIGEN (VCA) IGG, VCA IGM, AND EBV NUCLEAR ANTIGEN 1 IGG CHEMILUMINESCENT IMMUNOASSAYS FOR DETECTION OF EBV ANTIBODIES AND CATEGORIZATION OF EBV INFECTION STATUS USING IMMUNOFLUORESCENCE ASSAYS AS THE REFERENCE METHOD.CLINICAL AND VACCINE IMMUNOLOGY. VOL. 21. ISSUE 5. P. 684-688 | 14 | 93% | 3 |
Classes with closest relation at Level 1 |